Back to search

Article

Design and development of a urinary cell pellet mRNA PCR-based assay for progressive kidney disease: Nephro-Dx

2025-11-02

Abstract excerpt

Progressive chronic kidney disease (CKD) is a major source of public health spending. Current non-invasive tests estimate CKD but provide a minimal understanding of cell- or compartment-specific injury. The gold standard for CKD diagnosis is a kidney biopsy, which affords risks and is impractical to repeat multiple times. Hence, repeatable, non-invasive tests to estimate pathologic kidney injury for diagnoses, pro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df6b35a1-2a00-5172-bdc5-d4fe00241f4f
DOI
10.1101/2025.10.31.25338655
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Design and development of a urinary cell pellet mRNA PCR-based assay for progressive kidney disease: Nephro-DxDOI 10.1101/2025.10.31.25338655
Select a neighboring publication to make it the new centre.